News About: Goverment
Government to overhaul drug reclassification system
The Ministry of Health and Welfare plans to ameliorate the current drug reclassification system of prescription drugs and over the counter (OTC) drugs as part of its efforts to push for a regulation change.
The min...
285 high-priced antihypertensive drugs to be delisted from health insurance
The Health Insurance Review Assessment and Service said on September 15 it will exclude a total of 285 antihypertensive agents from health insurance coverage within this year, since they are deemed to less cost-effect...
Government set to implement drug pricing reform in October
The government has a plan to gradually lower drug prices in Korea. The plan to be implemented in October, draws a keen attention as Korea faces an urgent need to lower spending on drugs and curb the rising cost of hea...
NDM-1 to be designated as infectious disease
Starting in October, the government plans to control the multiple-drug resistant bacteria ‘NDM-1’ by designating it as “officially designated communicable disease” and running a surveillance system that receives a rea...
KFDA to back small business policy
The Korea Food and Drug Administration (KFDA) will provide various policy incentives for small-and medium-sized enterprises (SMEs) in the local pharmaceutical sector.
In a recent meeting with CEOs of 10 pharmaceuti...
KFDA to get tough over narcotics validation
The KFDA says that method validation on narcotics should be made available on three consecutive batches to ensure better quality, even though narcotics manufacturers said such validation rules are quite burdensome in ...
Korea health insurance to suffer 22 trillion won in deficit in 2030
The National Health Insurance will see about 22 trillion won in deficit in 2030, considering the number of ever-growing Koreans aged over 65, according to the Korea Institute for Health and Social Affairs (KIHASA).
...
KFDA suggests strict sealing process
The Korea Food and Drug Administration suggested that some of multinational drug manufacturers observe the sealing regulation of drugs before their release to pharmacies.
The Korean Pharmaceutical Association said ...
Medical bills for patients with spine disease will go down
The costs that individuals will have to shoulder for treatment of spine and joint diseases will go down from October thanks to the government’s plan to restructure the national health insurance scheme, the Ministry fo...
Drugmakers keen on expanded coverage of DMF system
The Korea Food and Drug Administration is considering providing assistance to industry, in particular Active Pharmaceutical Ingredient (API) manufacturers, on the requirements of drug substance as the drug agency inte...